HAEGTFTSDVSSYLE is a polypeptide from patent CN 102920658 B. GLP-I analog contains the sequence.
CAT No: R1410
HAEGTFTSDVSSYLE is a synthetic peptide corresponding to a specific amino acid sequence derived from the glucagon-like peptide-1 (GLP-1) family. As a bioactive peptide, it is of significant interest in the field of metabolic and endocrine research due to its structural and functional resemblance to endogenous incretin hormones. Its precise sequence and defined biochemical properties make it a valuable molecular tool for investigating peptide-receptor interactions, studying metabolic signaling pathways, and supporting the development of novel research models in peptide biology.
Receptor Binding Studies: As a representative GLP-1 analog, HAEGTFTSDVSSYLE is frequently utilized in receptor binding assays to characterize the affinity and specificity of ligand-receptor interactions. Researchers employ this peptide to examine how structural modifications influence binding to GLP-1 receptors, providing critical insights into the molecular determinants of peptide recognition and receptor activation. Such studies are foundational for elucidating the mechanisms underlying peptide hormone signaling and for guiding the rational design of next-generation peptide ligands.
Signal Transduction Research: The peptide serves as a robust tool for dissecting intracellular signaling cascades initiated by GLP-1 receptor engagement. By exposing cultured cells or tissue preparations to HAEGTFTSDVSSYLE, investigators can analyze downstream effects such as cyclic AMP production, kinase activation, and gene expression changes. These experiments enable a detailed understanding of how peptide hormones modulate cellular responses, offering a platform for comparative studies with other GLP-1 analogs and related peptides.
Peptide Structure-Activity Relationship (SAR) Analysis: HAEGTFTSDVSSYLE is often employed in systematic SAR studies to determine how sequence variations affect biological activity. By comparing its functional properties with those of other peptide variants, researchers can identify key residues responsible for receptor binding, stability, or bioactivity. These insights are instrumental in optimizing peptide design for research applications, including the creation of more selective or potent analogs for probing specific physiological processes.
Peptide Synthesis and Analytical Method Development: The well-defined sequence of HAEGTFTSDVSSYLE makes it an ideal reference standard in peptide synthesis optimization and analytical method validation. Laboratories use this peptide to calibrate chromatographic systems, refine purification protocols, and verify the accuracy of mass spectrometry-based identification techniques. Its application in these contexts supports the advancement of peptide manufacturing and quality control processes within research and industrial settings.
Metabolic Pathway Elucidation: In metabolic research, HAEGTFTSDVSSYLE is applied to model and dissect the regulatory roles of incretin peptides in glucose homeostasis and energy balance. Experimental systems utilizing this peptide facilitate the investigation of peptide-mediated effects on insulin secretion, nutrient sensing, and metabolic enzyme regulation. Such studies contribute to a deeper understanding of endocrine control mechanisms and provide a foundation for exploring metabolic dysfunction in various experimental models.
1. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
3. Cationic cell-penetrating peptides are potent furin inhibitors
5. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.